ArticleInvestigational new drugs2014

Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.

Laura Muñoz-Moreno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.